ONCO Share Price Performance
CA$1.10
-0.32 (-22.54%)
Price CA$1.10
Share Pricen/a
Onco-Innovations Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
ONCO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Onco-Innovations Limited Key Details
Last Reported Earnings
Jan 31, 2026
Next Reporting Earnings
n/a
- -0.25
- 100.00%
- -9,648.18%
- 0%
About ONCO
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3'-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. The company has a strategic collaboration with Nucro-Technics Inc. for the development of bioanalytical methods to support preclinical pharmacokinetic and biodistribution studies. Onco-Innovations Limited is headquartered in Calgary, Canada.
